Close Menu

NEW YORK – Berkeley Lights reported on Thursday a 16 percent increase in third quarter revenues, driven by higher service and consumables revenues.

For the three months ended Sept. 30, 2020 — its first full quarter operating as a public company — the Emeryville, California-based cell analysis firm reported $18.2 million in revenues, up from $15.7 million during the same period last year and beating the consensus Wall Street estimate of $15.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.